1) Lee, I. S., Lee, H. K., Dat, N. T., Lee,
M. S., Kim, J. W., Na, D. S., and Kim, Y. H. Lignans with inhibitory
activity against NFAT transcription from Schisandra chinensis.
Planta Med. 2003;69(1):63-64.
2) Sterbova, H., Sevcikova, P., Kvasnickova,
L., Glatz, Z., and Slanina, J. Determination of lignans in
Schisandra chinensis using micellar electrokinetic capillary
chromatography. Electrophoresis 2002;23(2):253-258.
3) Opletal, L., Krenkova, M., and Havlickova,
P. [Phytotherapeutic aspects of diseases of the circulatory system.
8. Chinese magnolia (Schisandra chinensis (Turcz.) Baill.):
production of the drugs and their evaluation, therapeutic and
dietary preparations]. Ceska.Slov.Farm. 2001;50(5):219-224. Opletal,
L., Krenkova, M., and Havlickova, P. [Phytotherapeutic aspects of
diseases of the circulatory system. 7. Schisandra chinensis (Turcz.)
Baill.): its composition and biological activity]. Ceska.Slov.Farm.
2001;50(4):173-180.
4) Chen, Y. G., Qin, G. W., Cao, L., Leng,
Y., and Xie, Y. Y. Triterpenoid acids from Schisandra propinqua with
cytotoxic effect on rat luteal cells and human decidual cells in
vitro. Fitoterapia 2001;72(4):435-437.
5) Sinclair, S. Chinese herbs: a clinical
review of Astragalus, Ligusticum, and Schizandrae. Altern.Med.Rev.
1998;3(5):338-344.
6) Sun, H. D., Qiu, S. X., Lin, L. Z., Wang,
Z. Y., Lin, Z. W., Pengsuparp, T., Pezzuto, J. M., Fong, H. H.,
Cordell, G. A., and Farnsworth, N. R. Nigranoic acid, a triterpenoid
from Schisandra sphaerandra that inhibits HIV-1 reverse
transcriptase. J.Nat.Prod. 1996;59(5):525-527.
7) Li, X. Y. Bioactivity of neolignans from
fructus Schizandrae. Mem.Inst.Oswaldo Cruz 1991;86 Suppl 2:31-37.
8) Liu, G. T. Pharmacological actions and
clinical use of fructus schizandrae. Chin Med.J.(Engl.)
1989;102(10):740-749.
9) Pan Q, Lu Q, Zhang K, Hu X.
Dibenzocyclooctadiene lingnans: a class of novel inhibitors of
P-glycoprotein. Cancer Chemother Pharmacol. 2005 Oct 18;:1-8
10) Wu MD, Huang RL, Kuo LM, Hung CC, Ong CW,
Kuo YH. The anti-HBsAg (human type B hepatitis, surface antigen) and
anti-HBeAg (human type B hepatitis, e antigen) C18
dibenzocyclooctadiene lignans from Kadsura matsudai and Schizandra
arisanensis. Chem Pharm Bull (Tokyo). 2003 Nov;51(11):1233-6
Department of Chemistry, National Sun Yat-Sen University, Kaohsiung,
Taiwan.
11) Mu Y, Zhang J, Zhang S, Zhou HH, Toma D,
Ren S, Huang L, Yaramus M, Baum A, Venkataramanan R, Xie W.
Traditional Chinese Medicines Wu Wei Zi (Schisandra chinensis Baill)
and Gan Cao (Glycyrrhiza uralensis Fisch) Activate PXR and Increase
Warfarin Clearance in Rats. J Pharmacol Exp Ther. 2005 Nov
12) Panossian A, Wagner H. Stimulating
effect of adaptogens: an overview with particular reference to their
efficacy following single dose administration. Phytother Res. 2005
Oct;19(10):819-38.
13) Pan Q, Lu Q, Zhang K, Hu X.
Dibenzocyclooctadiene lingnans: a class of novel inhibitors of
P-glycoprotein. Cancer Chemother Pharmacol. 2005 Oct 18;:1-8 Li YH,
Lu XY.
14) Investigation on the origin of 5-HMF in
Shengmaiyin decoction by RP-HPLC method. J Zhejiang Univ Sci B. 2005
Oct;6(10):1015-21.
15) Chang GT, Kang SK, Kim JH, Chung KH,
Chang YC, Kim CH. Inhibitory effect of the Korean herbal medicine,
Dae-Jo-Whan, on platelet-activating factor-induced platelet
aggregation. J Ethnopharmacol. 2005 Dec 1;102(3):430-9. Epub 2005
Aug 26.
16) Melhem A, Stern M, Shibolet O, Israeli
E, Ackerman Z, Pappo O, Hemed N, Rowe M, Ohana H, Zabrecky G,
Cohen R, Ilan Y. Treatment of chronic hepatitis C virus infection
via antioxidants: results of a phase I clinical trial. J Clin
Gastroenterol. 2005 Sep;39(8):737-42.
17) Yang LQ, Wu XY, Xu ZQ, Hou HR, Fu
HZ.[Research progress on determination of lignans from Schiandra
chinensis and its preparations] Zhongguo Zhong Yao Za Zhi. 2005
May;30(9):650-3.
18) Peng J, Fan G, Qu L, Zhou X, Wu Y.
Application of preparative high-speed counter-current chromatography
for isolation and separation of schizandrin and gomisin A from
Schisandra chinensis. J Chromatogr A. 2005 Aug 5;1082(2):203-7.
19) Tian K, Qi S, Cheng Y, Chen X, Hu Z.
Separation and determination of lignans from seeds of Schisandra
species by micellar electrokinetic capillary chromatography using
ionic liquid as modifier. J Chromatogr A. 2005 Jun
17;1078(1-2):181-7.
20) Anjia C, Cunhong L, Wenhua G, Zhide H,
Xingguo C. Separation and determination of active components
in Schisandra chinensis Baill. and its medicinal preparations by
non-aqueous capillary electrophoresis. Biomed Chromatogr. 2005
Sep;19(7):481-7.
21) Li RT, Han QB, Zheng YT, Wang RR, Yang
LM, Lu Y, Sang SQ, Zheng QT, Zhao QS, Sun HD. Structure and
anti-HIV activity of micrandilactones B and C, new nortriterpenoids
possessing a unique skeleton from
Schisandra micrantha. Chem Commun (Camb). 2005 Jun 21;(23):2936-8.
22) Xiao WL, Zhu HJ, Shen YH, Li RT, Li SH,
Sun HD, Zheng YT, Wang RR, Lu Y, Wang C, Zheng QT. Lancifodilactone
G: a unique nortriterpenoid isolated from Schisandra lancifolia and
its anti-HIV activity. Org Lett. 2005 May 26;7(11):2145-8.
23) Chen YG, Wu ZC, Gui SH, Lv YP, Liao XR,
Halaweish F. Lignans from Schisandra hernyi with DNA cleaving
activity and cytotoxic effect on leukemia and Hela cells in vitro.
Fitoterapia. 2005 Jun;76(3-4):370-3.
24) Huang T, Shen P, Shen Y. Preparative
separation and purification of deoxyschisandrin and gamma-schisandrin
from Schisandra chinensis (Turcz.) Baill by high-speed
counter-current chromatography. J Chromatogr A. 2005 Feb
25;1066(1-2):239-42.
25) Xiao WL, Li RT, Li SH, Li XL, Sun HD,
Zheng YT, Wang RR, Lu Y, Wang C, Zheng QT. Lancifodilactone F:
a novel nortriterpenoid possessing a unique skeleton from Schisandra
lancifolia and its anti-HIV activity. Org Lett. 2005 Mar
31;7(7):1263-6.
26) Li RT, Xiao WL, Shen YH, Zhao QS, Sun
HD. Structure characterization and possible biogenesis of three
new families of nortriterpenoids: schisanartane, schiartane, and
18-norschiartane. Chemistry. 2005 May 6;11(10):2989-96.
27) Kushnerova NF, Sprygin VG, Rakhmanin IuA.
[Influence of complex plant polyphenol preparation Eklikit
on process of liver functions recovery after alcohol intoxication]
Biomed Khim. 2004;50(6):605-11.
28) Wang LW, Liu XM, Lu GH, Gao NN, Xiao PG.
[Primary research of pharmacological effects of PEC on mice]
Zhongguo Zhong Yao Za Zhi. 2004 Jun;29(6):568-9, 593.
29) Kang SY, Lee KY, Koo KA, Yoon JS, Lim
SW, Kim YC, Sung SH. ESP-102, a standardized combined extract
of Angelica gigas, Saururus chinensis and Schizandra chinensis,
significantly improved scopolamine-induced memory impairment in
mice. Life Sci. 2005 Feb 25;76(15):1691-705.
30) Kuo YH, Wu MD, Hung CC, Huang RL, Yang
Kuo LM, Shen YC, Ong CW. Syntheses of C(18) dibenzocyclooctadiene
lignan derivatives as anti-HBsAg and anti-HBeAg agents. Bioorg Med
Chem. 2005
Mar 1;13(5):1555-61.
31) Chiu PY, Ko KM. Schisandrin B protects
myocardial ischemia-reperfusion injury partly by inducing Hsp25 and
Hsp70 expression in rats. Mol Cell Biochem. 2004
Nov;266(1-2):139-44.
32) Wang YH, Gao JP, Chen DF. [Determination
of lignans of Schisandra medicinal plants by HPLC] Zhongguo Zhong
Yao Za Zhi. 2003 Dec;28(12):1155-60.
33) Hu Y, Liang YZ, Li BY, Li XN, Du YP.
Multicomponent spectral correlative chromatography applied to
complex herbal medicines. J Agric Food Chem. 2004 Dec
29;52(26):7771-6.
34) Opletal L, Sovova H, Bartlova M.
Dibenzo[a,c]cyclooctadiene lignans of the genus Schisandra:
importance, isolation and determination. J Chromatogr B Analyt
Technol Biomed Life Sci. 2004 Dec 5;812(1-2):357-71.
35) Pan WJ, Xiao XH, Xiao X, Yuan HL, Zhao
YL. [Studies on extraction process of Fructus Schisandrae
chinensis and Fructus Ligustri lucidi in gandening tablet] Zhongguo
Zhong Yao Za Zhi. 2004 Aug;29(8):743-5.
36) Wu T, Kong DY, Li HT. [Identification of
the structure of two new nitro group phenolic glycosides from
Schisandra propinqua (Wall. ) Baill var. intermidia A. C. Smith] Yao
Xue Xue Bao. 2004 Jul;39(7):534-7.
37) Iwata H, Tezuka Y, Kadota S, Hiratsuka
A, Watabe T. Identification and characterization of potent CYP3A4
inhibitors in Schisandra fruit extract. Drug Metab Dispos. 2004
Dec;32(12):1351-8. Epub 2004 Sep 1.
38) Huang L, Chen L, Zhang Z. [Pathological
observations of Fructus Schisandrae polysaccharide on anti-tumor
effects in S180-bearing mice] Zhong Yao Cai. 2004 Mar;27(3):202-3.
39) Lee YJ, Cho JY, Kim JH, Park WK, Kim DK,
Rhyu MR. Extracts from Schizandra chinensis fruit activate estrogen
receptors: a possible clue to its effects on nitric oxide-mediated
vasorelaxation. Biol Pharm Bull. 2004 Jul;27(7):1066-9.
40) Kim SR, Lee MK, Koo KA, Kim SH, Sung SH,
Lee NG, Markelonis GJ, Oh TH, Yang JH, Kim YC.
Dibenzocyclooctadiene lignans from Schisandra chinensis protect
primary cultures of rat cortical
cells from glutamate-induced toxicity. J Neurosci Res. 2004 May
1;76(3):397-405.
41) Gao JP, Wang YH, Qiao CF, Chen DF.
[Ribosomal DNA ITS sequences analysis of the Chinese crude drug
fructus schisandrae sphenantherae and fruts of Schisandra viridis]
Zhongguo Zhong Yao Za Zhi. 2003
Aug;28(8):706-10.
42) Guo J, Liu LH, Mei SX, Zhao JF, Ma ZR,
Li L. [Studies on chemical constituents from the stems of Schisandra
sphaerandra] Zhongguo Zhong Yao Za Zhi. 2003 Feb;28(2):138-40.
43) Wu XF, Chen H, Zhao ZR. [Determination
of schisandrin in shengmaiyin by HPLC] Zhongguo Zhong Yao Za Zhi.
2003 Jan;28(1):39-40, 72.
44) Chen YG, Wu ZC, Lv YP, Gui SH, Wen J,
Liao XR, Yuan LM, Halaweish F. Triterpenoids from Schisandra
henryi with cytotoxic effect on leukemia and Hela cells in vitro.
Arch Pharm Res. 2003 Nov;26(11):912-6.
45) Molander GA, George KM, Monovich LG.
Total synthesis of (+)-isoschizandrin utilizing a samarium(II)
iodide-promoted 8-endo ketyl-olefin cyclization. J Org Chem. 2003
Dec 12;68(25):9533-40.
46) Wu MD, Huang RL, Kuo LM, Hung CC, Ong CW,
Kuo YH. The anti-HBsAg (human type B hepatitis, surface antigen) and
anti-HBeAg (human type B hepatitis, antigen) C18
dibenzocyclooctadiene lignans from Kadsura matsudai and Schizandra
arisanensis. Chem Pharm Bull (Tokyo). 2003 Nov;51(11):1233-6.
47) Li RT, Han QB, Zhao AH, Sun HD.
Micranoic acids A and B: two new octanortriterpenoids from
Schisandra
micrantha. Chem Pharm Bull (Tokyo). 2003 Oct;51(10):1174-6.
48) Nakagiri R, Oda H, Kamiya T. Small scale
rat hepatocyte primary culture with applications for screening
hepatoprotective substances. Biosci Biotechnol Biochem. 2003
Aug;67(8):1629-35.
49) Chu MQ, Liu GJ. [Kinetic model for
extraction process of Chinese traditional medicine] Yao Xue Xue Bao.
2002 Jul;37(7):559-62.
50) Ram VJ. Herbal preparations as a source
of hepatoprotective agents. Drug News Perspect. 2001
Aug;14(6):353-63.
51) Amaryan G, Astvatsatryan V, Gabrielyan
E, Panossian A, Panosyan V, Wikman G. Double-blind,
placebo-controlled, randomized, pilot clinical trial of ImmunoGuard--a
standardized fixed combination of Andrographis paniculata Nees, with
Eleutherococcus senticosus Maxim, Schizandra chinensis Bail. and
Glycyrrhiza glabra L. extracts in patients with Familial
Mediterranean Fever. Phytomedicine. 2003 May;10(4):271-85.
52) Yang SB. [Study on supercritical CO2
fluid extraction and separation of components from fruits of
Schisandra sphenanthera] Zhongguo Zhong Yao Za Zhi. 2001
Nov;26(11):755-7.
53) Chen YG, Qin GW, Xie YY. [Studies on
chemical constituents of Schisandra propinqua (Wall.) Hook. f. et
Thoms] Zhongguo Zhong Yao Za Zhi. 2001 Oct;26(10):694-7.
54) Li RT, Zhao QS, Li SH, Han QB, Sun HD,
Lu Y, Zhang LL, Zheng QT. Micrandilactone A: a novel triterpene from
Schisandra micrantha. Org Lett. 2003 Apr 3;5(7):1023-6.
55) Li XN, Cui H, Song YQ, Liang YZ, Chau
FT. Analysis of volatile fractions of Schisandra chinensis (Turcz.)
Baill. using GC-MS and chemometric resolution. Phytochem Anal. 2003
Jan-Feb;14(1):23-33.
56) Li XN, Cui H, Song YQ, Liang YZ.
[Analysis of the essential oil of Schisandra chinensis (Turcz.)
Baill. with GC/MS] Yao Xue Xue Bao. 2001 Mar;36(3):215-9.
57) Lee IS, Lee HK, Dat NT, Lee MS, Kim JW,
Na DS, Kim YH. Lignans with inhibitory activity against NFAT
transcription from Schisandra chinensis. Planta Med. 2003
Jan;69(1):63-4. Chiu PY, Mak DH, Poon MK, Ko KM. In vivo antioxidant
action of a lignan-enriched extract of Schisandra fruit and an
anthraquinone-containing extract of Polygonum root in comparison
with schisandrin B and emodin. Planta Med. 2002 Nov;68(11):951-6.
58) Zhang L, Chen Z, Li X. [Seed germinative
characteristics and embryo development of Schisandra chinensis (Turcz.)
Bail.] Zhongguo Zhong Yao Za Zhi. 1999 Aug;24(8):459-61, 510.
59) Chang J, Xie J. [Total synthesis of
schizandrin, the main active ingredient isolated from the Chinese
herbal medicine fructus schizandrae] Yao Xue Xue Bao. 1998
Jun;33(6):424-8.
60) Bartlova M, Opletal L, Chobot V, Sovova
H. Liquid chromatographic analysis of supercritical carbon dioxide
extracts of Schizandra chinensis. J Chromatogr B Analyt Technol
Biomed Life Sci. 2002 Apr 25;770(1-2):283-9.
61) Kuo YH, Kuo LM, Chen CF. Four New C19
Homolignans, Schiarisanrins A, B, and D and Cytotoxic
Schiarisanrin C, from Schizandra arisanensis. J Org Chem. 1997 May
16;62(10):3242-3245.
62) Kuo YH, Li SY, Wu MD, Huang RL, Yang Kuo
LM, Chen CF. A new anti-HBeAg lignan, kadsumarin A, from
Kadsura matsudai and Schizandra arisanensis. Chem Pharm Bull
(Tokyo). 1999 Jul;47(7):1047-8.
63) Hsieh MT, Tsai ML, Peng WH, Wu CR.
Effects of Fructus schizandrae on cycloheximide-induced amnesia in
rats. Phytother Res. 1999 May;13(3):256-7.
64) Panossian AG, Oganessian AS,
Ambartsumian M, Gabrielian ES, Wagner H, Wikman G. Effects of heavy
physical exercise and adaptogens on nitric oxide content in human
saliva. Phytomedicine. 1999 Mar;6(1):17-26.
65) Bol'shakova IV, Lozovskaia EL,
Sapezhinskii II. [Photosensitizing and photoprotective properties of
extracts from groups of medicinal plants] Biofizika. 1997
Jul-Aug;42(4):926-32.
66) Bol'shakova IV, Lozovskaia EL,
Sapezhinskii II. [Antioxidant properties of a series of extracts
from medicinal plants] Biofizika. 1997 Mar-Apr;42(2):480-3.
67) Nishiyama N, Chu PJ, Saito H. An herbal
prescription, S-113m, consisting of biota, ginseng and schizandra,
improves learning performance in senescence accelerated mouse. Biol
Pharm Bull. 1996 Mar;19(3):388-93.
68) Ohtaki Y, Hida T, Hiramatsu K, Kanitani
M, Ohshima T, Nomura M, Wakita H, Aburada M, Miyamoto KI.
Deoxycholic acid as an endogenous risk factor for
hepatocarcinogenesis and effects of gomisin A, a
lignan component of Schizandra fruits. Anticancer Res. 1996
Mar-Apr;16(2):751-5.
69) Miyamoto K, Hiramatsu K, Ohtaki Y,
Kanitani M, Nomura M, Aburada M. Effects of gomisin A on the
promotor action and serum bile acid concentration in
hepatocarcinogenesis induced by
3'-methyl-4-dimethylamino-azobenzene. Biol Pharm Bull. 1995
Oct;18(10):1443-5.
70) Wang JP, Raung SL, Hsu MF, Chen CC.
Inhibition by gomisin C (a lignan from Schizandra chinensis) of
the respiratory burst of rat neutrophils. Br J Pharmacol. 1994
Nov;113(3):945-53.
71) Nomura M, Ohtaki Y, Hida T, Aizawa T,
Wakita H, Miyamoto K. Inhibition of early
3-methyl-4-dimethylaminoazobenzene-induced hepatocarcinogenesis by
gomisin A in rats. Anticancer Res. 1994 Sep-Oct;14(5A):1967-71.
72) Ohtaki Y, Nomura M, Hida T, Miyamoto K,
Kanitani M, Aizawa T, Aburada M. Inhibition by gomisin A, a
lignan compound, of hepatocarcinogenesis by
3'-methyl-4-dimethylaminoazobenzene in rats. Biol Pharm
Bull. 1994 Jun;17(6):808-14.
73) Nomura M, Nakachiyama M, Hida T, Ohtaki
Y, Sudo K, Aizawa T, Aburada M, Miyamoto KI. Gomisin A, a
lignan component of Schizandora fruits, inhibits development of
preneoplastic lesions in rat liver by
3'-methyl-4-dimethylamino-azobenzene. Cancer Lett. 1994 Jan
15;76(1):11-8.
74) Jiaxiang N, Fujii K, Sato N, Yuge O.
Inhibitory effect of gomisi on reductive metabolism of halothane. J
Appl Toxicol. 1993 Nov-Dec;13(6):385-8.
75) Cui YY, Wang MZ. Aspects of schizandrin
metabolism in vitro and in vivo. Eur J Drug Metab Pharmacokinet.
1993 Apr-Jun;18(2):155-60.
76) Cui YY, Wang MZ. [Metabolic
transformation of schizandrin] Yao Xue Xue Bao. 1992;27(1):57-63.
77) Mizoguchi Y, Kawada N, Ichikawa Y,
Tsutsui H. Effect of gomisin A in the prevention of acute hepatic
failure induction. Planta Med. 1991 Aug;57(4):320-4.
78) Zhang L, Niu X. [Effects of schizandrol
A on monoamine neurotransmitters in the central nervous system]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1991 Feb;13(1):13-6.
79) Molokovskii DS, Davydov VV, Tiulenev VV.
[The action of adaptogenic plant preparations in experimental
alloxan diabetes] Probl Endokrinol (Mosk). 1989 Nov-Dec;35(6):82-7.
80)Nagai H, Yakuo I, Aoki M, Teshima K, Ono
Y, Sengoku T, Shimazawa T, Aburada M, Koda A. The effect of gomisin
A on immunologic liver injury in mice. Planta Med. 1989
Feb;55(1):13-7.
81) Liu GT.[Biochemical and pharmacologic
effects of wuweizi (Schizandra chinensis (Turcz.) Baill.) and its
chemical contents on animal livers] Sheng Li Ke Xue Jin Zhan. 1988
Jul;19(3):197-203.
82) Hernandez DE, Hancke JL, Wikman G.
Evaluation of the anti-ulcer and antisecretory activity of extracts
of Aralia elata root and Schizandra chinensis fruit in the rat. J
Ethnopharmacol. 1988 May-Jun;23(1):109-14.
83) Takeda S, Kase Y, Arai I, Hasegawa M,
Sekiguchi Y, Funo S, Aburada M, Hosoya E, Mizoguchi Y, Morisawa
S.[Effects of TJN-101
((+)-(6s,7s,R-biar)-5,6,7,8-tetrahydro-1,2,3,12-tetramethoxy-6,7
-dimethyl-10,11-methylenedioxy-6-dibenzo [a,c] cyclooctenol) on
liver regeneration after partial hepatectomy, and on regional
hepatic blood flow and fine structure of the liver in normal rats]
Nippon Yakurigaku Zasshi. 1986 Oct;88(4):321-30.
84) Hendrich S, Bjeldanes LF. Effects of
dietary Schizandra chinensis, brussels sprouts and Illicium verum
extracts on carcinogen metabolism systems in mouse liver. Food Chem
Toxicol. 1986 Sep;24(9):903-12.
85) Takeda S, Maemura S, Sudo K, Kase Y,
Arai I, Ohkura Y, Funo S, Fujii Y, Aburada M, Hosoya E. [Effects
of gomisin A, a lignan component of Schizandra fruits, on
experimental liver injuries and liver microsomal drug-metabolizing
enzymes] Nippon Yakurigaku Zasshi. 1986 Feb;87(2):169-87.
86) Maeda S, Takeda S, Miyamoto Y, Aburada
M, Harada M. Effects of gomisin A on liver functions in hepatotoxic
chemicals-treated rats. Jpn J Pharmacol. 1985 Aug;38(4):347-53.
87) Long ZZ, Xie SS. [Experimental study on
the enhancement of the immunosuppressive effect of cortisone by
wurenchun, an extract of Schizandra chinensis Baill] Zhong Xi Yi Jie
He Za Zhi. 1985 Jun;5(6):361-2, 325.
88) Takeda S, Funo S, Iizuka A, Kase Y, Arai
I, Ohkura Y, Sudo K, Kiuchi N, Yoshida C, Maeda S, et al.
[Pharmacological studies on schizandra fruits. III. Effects of
wuweizisu C, a lignan component of schizandra fruits, on
experimental liver injuries in rats] Nippon Yakurigaku Zasshi. 1985
Mar;85(3):193-208.
89) Salbe AD, Bjeldanes LF. The effects of
dietary brussels sprouts and Schizandra chinensis on the xenobiotic-metabolizing
enzymes of the rat small intestine. Food Chem Toxicol. 1985
Jan;23(1):57-65.
90) Sosnova TL, Golubev VV, Plekhanova NA,
Afanas'ev AN. [Stimulating effects of eleuterococcus and Chinese
schizandra used for prevention of visual fatigue during work
connected with color discrimination] Gig Sanit. 1984 Dec;(12):7-9.
91) Hikino H, Kiso Y, Taguchi H, Ikeya Y.
Antihepatotoxic actions of lignoids from Schizandra chinensis
fruits. Planta Med. 1984 Jun;50(3):213-8.
92) Xie JX, Zhou J, Zhang CZ, Yang JH, Chen
JX. Studies on antihepatitic drugs. Total synthesis of (+/-)schizandrin
C and its analogs. Sci Sin [B]. 1983 Dec;26(12):1291-303.
93) Hendrich S, Bjeldanes LF. Effects of
dietary cabbage, Brussels sprouts, Illicium verum, Schizandra
chinensis and alfalfa on the benzo[alpha]pyrene metabolic system in
mouse liver. Food Chem Toxicol. 1983 Aug;21(4):479-86.
94) Nakajima K, Taguchi H, Ikeya Y, Endo T,
Yosioka I. [Constituents of Schizandra chinensis Baill. XIII.
Quantitative analysis of lignans in the fruits of Schizandra
chinensis Baill. by high performance liquid chromatography] Yakugaku
Zasshi. 1983 Jul;103(7):743-9.
95) Wang MZ, Li BL. [High performance liquid
chromatographic analysis of active ingredients of Schizandra] Yao
Xue Xue Bao. 1983 Mar;18(3):209-14.
96) Maeda S, Sudo K, Miyamoto Y, Takeda S,
Shinbo M, Aburada M, Ikeya Y, Taguchi H, Harada M.
[Pharmacological studies on schizandra fruits. II. Effects of
constituents of shizandra fruits on drugs induced hepatic damage in
rats] Yakugaku Zasshi. 1982 Jun;102(6):579-88.
97) Maeda S, Sudo K, Aburada M, Ikeya Y,
Taguchi H, Yoshioka I, Harada M. [Pharmacological studies on
Schizandra fruit. I. General pharmacological effects of gomisin A
and schizandrin] Yakugaku Zasshi.
1981 Nov;101(11):1030-41.
98) Takani M, Ohya K, Takahashi K. Studies
on constituents of medicinal plants. XXII. Constituents of
Schizandra nigra Max. Chem Pharm Bull (Tokyo). 1979
Jun;27(6):1422-5.
99) Ikeya Y, Taguchi H, Yosioka I, Iitaka Y,
Kobayashi H. The constituents of Schizandra chinensis Baill. II. The
structure of a new lignan, gomisin D. Chem Pharm Bull (Tokyo). 1979
Jun;27(6):1395-401.
100) Ikeya Y, Taguchi H, Yosioka I,
Kobayashi H. The constituents of Schizandra chinensis Baill. I.
Isolation and structure determination of five new lignans, gomisin
A, B, C, F and G, and the absolute structure of schizandrin. Chem
Pharm Bull (Tokyo). 1979 Jun;27(6):1383-94.
101) Takahashi K, Takani M. Studies of
constituents of medicinal plants. XVII. Constituents of Schizandra
nigra Max. and their carbon-13 nuclear magnetic resonance spectra.
Chem Pharm Bull (Tokyo). 1976 Sep;24(9):2000-6.
102) Yan-yong C, Zeng-bao S, Lian-niang L.
Studies of Fructus schizandrae. IV. Isolation and determination of
the active compounds (in lowering high SGPT levels) of Schizandra
chinensis Baill. Sci Sin. 1976 Mar-Apr;19(2):276-90.
103) Suprunov NI, Samoilenko LI.
[Standardization of schizandra preparations] Farmatsiia. 1975
Mar-Apr;24(2):35-7.
104) Ma TS, Roper R. Microchemical
investigation of medicinal plants. I. The antitubercular principle
in Prunus mume and Schizandra chinensis. Mikrochim Acta.
1968;(1):167-81.
105) Voevodina ON, Volkova VD. [Effect of
small doses of Schizandra chinensis on situation orienting
conditioned reflexes in normal and irradiated animals] Farmakol
Toksikol. 1965 Mar-Apr;28(2):135-7.79016
106) Lapaev II.[On the effectiveness of the
juice of schizandra chinensis in thrombocytopenia] Voen Med Zh. 1965
Jan;1:79-80.
107) LASTOVETSKII VV, ROMAS RS.
[PECULIARITIES OF THE INTERACTION OF SIGNAL SYSTEMS UNDER THE
INFLUENCE OF SCHIZANDRA CHINENSIS.] Zh Vyssh Nerv Deiat Im I P
Pavlova. 1963 Jul-Aug;13:604-9.
108) SHCHERBAKOVA MN. [Determination of
vitamin E in the oil of Schizandra chinensis. I.] Aptechn Delo. 1963
Jan-Feb;12:33-6. VOLYNSKII ZM, MUKUSHKIN MK. [On the utilization of
an experimental form of hypertension in the evaluation of the
effectiveness of Schizandra chinensis in atherosclerosis.] Biull
Eksp Biol Med. 1960 Nov;50:66-70.
109) HURYNOWICZ J, NOWICKA H, BARGIEL Z.
[Effect of Schizandra chinensis Baill on the EEG of the rabbit in
acute fatigue.] J Physiol (Paris). 1960 Jan-Feb;52:122-4. HURYNOWICZ
J, JANISZEWSKI L, KADZIELA W. [Effects of Schisandra chinensis on
chronaxy of the neurovascular system of thumb.] J Physiol (Paris).
1958 Mar;50(2):321-5.
110) LAPAEV II. [Result of treatment of
chronic gastritis with Schizandra chinensis.] Klin Med (Mosk). 1958
Feb;36(2):109-12.
111) NOWICKA H, NAREBSKI J, JANISZEWSKI L,
HURYNOWICZ J, BARGIEL Z. [Effect of Schizandra chinensis on
electroencephalograms in rabbits following hypothermia.] Acta
Physiol Pol. 1957;8(3-3a):488-90.
112) NOWICKA H, BARGIEL Z, NAREBSKI J,
JANISZEWSKI L, HURYNOWICZ J. [Effect of Schizandra chinensis on
vestibular chronaxy following hypothermia in rabbits.] Acta Physiol
Pol. 1957;8(3-3a):487-8.
113) TOLEV I, TOLEVA P, BOIADZHIEV A.
[Therapeutic effects of Schizandra chinensis preparation for
external use in certain dermatoses.] Suvr Med (Sofiia).
1957;8(3):31-7.
114) CHMIELEWSKA Z, NAREBSKI J, HURYNOWICZ
J. [Effect of Schizandra chinensis on EEG in exhausted
neurotics with depressive manifestations; preliminary communication.
II.] Neurol Neurochir Psychiatr Pol. 1957 Jan-Feb;7(1):41-51.
115) HURYNOWICZ J. [Effects of Schizandra
chinensis on EEG of a man exhausted by mental work; preliminary
note No. 1.] Neurol Neurochir Psychiatr Pol. 1956
Nov-Dec;6(6):781-9.
116) KONSTANTINOV AA. [Stimulating and tonic
effects of Schizandra chinensis and ginseng.] Vopr Med Khim.
1956 Jul-Aug;2(4):287-92.
117) PETKOV VD. [Data on stimulating effect
of Schizandra chinensis.] Suvr Med (Sofiia). 1956;7(5):23-30.
118) SOROKHTIN GN, MINUT-SOROKHTINA OP,
TURBINA LV. [Effect of Schizandra chinensis and ginseng root
extract on cerebral cortical rhythms.] Zh Vyssh Nerv Deiat Im I P
Pavlova. 1955 Sep-Oct;5(5):747-55.
119) EFIMOVA VE, GLEBOVA NF, ORLOVA
MI.[Effect of Schizandra chinensis and ginseng on the higher nervous
function in dogs.] Zh Vyssh Nerv Deiat Im I P Pavlova. 1955
Sep-Oct;5(5):741-6.
120) SOROKHTIN GN. [Results of
laboratory-clinical investigations of stimulating and tonic effect
of Schizandra chinensis and of ginseng in normal and pathological
conditions in animal and man.] Farmakol Toksikol. 1955
May-Jun;18(3):53-5.
121) Hong YH. Oriental Materia Medica:A
Concise Guide.Long Beach, CA: Oriental Healing Arts Institute; 1986.
122) Bensky D, Gamble A. Chinese Herbal
Medicine : Materia Medica, Revised Edition. Seattle, WA: Eastland
Press; 1993.
